ACLX
Price
$86.68
Change
+$0.24 (+0.28%)
Updated
Nov 5, 04:48 PM (EDT)
6 days until earnings call
CRSP
Price
$50.41
Change
-$0.18 (-0.36%)
Updated
Nov 5, 04:00 PM (EDT)
105 days until earnings call
Ad is loading...

ACLX vs CRSP

Header iconACLX vs CRSP Comparison
Open Charts ACLX vs CRSPBanner chart's image
Arcellx
Price$86.68
Change+$0.24 (+0.28%)
Volume$6.74K
CapitalizationN/A
CRISPR Therapeutics AG
Price$50.41
Change-$0.18 (-0.36%)
Volume$224.97K
CapitalizationN/A
View a ticker or compare two or three
ACLX vs CRSP Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACLX vs. CRSP commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and CRSP is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ACLX: $86.44 vs. CRSP: $50.62)
Brand notoriety: ACLX and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 141% vs. CRSP: 132%
Market capitalization -- ACLX: $4.65B vs. CRSP: $4.31B
ACLX [@Biotechnology] is valued at $4.65B. CRSP’s [@Biotechnology] market capitalization is $4.31B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 3 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 3 bullish, 5 bearish.
  • CRSP’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than ACLX.

Price Growth

ACLX (@Biotechnology) experienced а +1.71% price change this week, while CRSP (@Biotechnology) price change was +1.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

CRSP is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($4.65B) has a higher market cap than CRSP($4.31B). ACLX YTD gains are higher at: 55.748 vs. CRSP (-19.137). ACLX has higher annual earnings (EBITDA): -46.86M vs. CRSP (-335.17M). ACLX has more cash in the bank: 517M vs. CRSP (484M). ACLX has less debt than CRSP: ACLX (74.3M) vs CRSP (231M). CRSP has higher revenues than ACLX: CRSP (200M) vs ACLX (145M).
ACLXCRSPACLX / CRSP
Capitalization4.65B4.31B108%
EBITDA-46.86M-335.17M14%
Gain YTD55.748-19.137-291%
P/E RatioN/AN/A-
Revenue145M200M73%
Total Cash517M484M107%
Total Debt74.3M231M32%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXCRSP
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 21 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
75%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMAX34.560.20
+0.58%
MFS Emerging Markets Equity A
HNSGX14.780.07
+0.48%
Harbor Small Cap Growth Retirement
MDDRX10.19N/A
N/A
MassMutual Diversified Value R4
FSEPX12.87-0.02
-0.16%
Fidelity Advisor Sustainable U.S. Eq M
STSOX42.02-0.08
-0.19%
Sterling Capital SmCp Val C

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CRSP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+0.31%
CRSP - ACLX
49%
Loosely correlated
-0.28%
BEAM - ACLX
47%
Loosely correlated
+6.24%
KYMR - ACLX
46%
Loosely correlated
+1.29%
ALLO - ACLX
45%
Loosely correlated
+10.29%
RCKT - ACLX
45%
Loosely correlated
-0.91%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-0.28%
BEAM - CRSP
73%
Closely correlated
+6.24%
EDIT - CRSP
66%
Loosely correlated
-1.03%
NTLA - CRSP
64%
Loosely correlated
+2.30%
PRME - CRSP
60%
Loosely correlated
-1.49%
RXRX - CRSP
57%
Loosely correlated
+3.44%
More